Navigation Links
Emerging Growth Pharmaceutical Company Creates Gravitational Pull Towards Their Products
Date:1/30/2013

LONDON, January 30, 2013 /PRNewswire/ --

EmergingGrowth.com, a leading digital financial media company, discusses Sunesis Pharmaceuticals, Amgen, Inc., Gilead Sciences and Biogen Idec, Inc.

The pharmaceutical sector is a very lucrative and competitive industry. And for emerging growth companies, it is difficult to make a meaningful impact in this cutthroat industry.

Sunesis Pharmaceuticals, Inc. (NASDAQ: SNSS) has built a highly experienced cancer drug development organization committed to advancing its lead product candidate, Vosaroxin, to improve the lives of people with cancer.

Sunesis Pharmaceuticals' work translates to a rosy top line as demonstrated by the $25 million it earned from a previously announced royalty purchase agreement with Royalty Pharma. It took possession of $15 million from the second tranche of a 2011 venture loan facility. It raised $17.3 million from the sale of 3.6 million shares of common stock and $1.4 million from the gross exercise of 0.6 million warrants to purchase common stock. This not only shows that Sunesis is able to raise capital for research purposes, but it also represents the company's keen interest in creating shareholder value.

The company is in the follow-up stage of trials of Vosaroxin, having completed a Phase 2 trial in ovarian cancer patients in 2010. However, broader market tailwinds will propel the company through the next decade. Vosaroxin is a first-in-class anticancer quinolone derivative, a class of compounds that has not been used previously for the treatment of cancer.  As of now, notable breakthroughs are being made with the drug, particularly as complete remissions have been observed in patients treated with Vosaroxin in combination with Cytarabine.

Just like its bigger competitors, Amgen Inc. (NASDAQ:

SOURCE EmergingGrowth.com
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Cumberland Emerging Technologies Expands Life Sciences Center
2. Innovative CA Tumor Marker Tests Technologies and Emerging Markets
3. Emerging Data on USL261 (Intranasal Midazolam) to Be Presented at the 66th Annual Meeting of the American Epilepsy Society
4. Innovative Hematology and Flow Cytometry Technologies and Emerging Markets
5. Henry Schein Announces Featured Speakers For The "Recovery Empowerment Symposium: Emerging From The Storm"
6. Cepheid Announces Executive Vice President Emerging Markets
7. Emerging Pharma Catalysts: H2 2012
8. As Medical Device Sales Jump in Emerging Markets, Organizations Embrace Outsourcing Clinical Activities
9. Agricultural Biotechnology: Emerging Technologies and Global Markets
10. Global Markets for Enzyme Inhibitors -- Focus on Emerging Markets
11. Wound Care Management Market to 2018 - Advanced Wound Care Modalities and an Expanding Patient Base Create Significant Growth Opportunities in Emerging Countries
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... Research and Markets ( ... "Investigation Report on China,s Ranibizumab Market, 2012-2019" report ... was approved by CFDA to treat wet age- related ... product of Novartis, is available in the Chinese market. ... drug for the treatment of wet AMD in ...
(Date:8/28/2015)... Company plc ("Perrigo") (NYSE: PRGO ; TASE) today ... OTC brands from GSK in an all cash transaction ... demonstration of Perrigo,s unique ability to maximize brand value ... countries.  Perrigo Chairman, President and CEO ... to complete this transaction, which clearly demonstrates our ability ...
(Date:8/28/2015)... PUNE, India , August 28, 2015 ... Essential Oils), Livestock (Pork/Swine, Poultry, Ruminant, and Aquaculture), & by ... , Asia-Pacific , and Rest of ... by MarketsandMarkets, The global market for Eubiotics was valued at ... USD 7.05 Billion by 2020, at a CAGR of 7.4% ...
Breaking Medicine Technology:Investigation Report on China's Ranibizumab Market, 2012-2019 2Perrigo Completes Acquisition of Leading Portfolio of OTC Brands from GSK 2Perrigo Completes Acquisition of Leading Portfolio of OTC Brands from GSK 3Perrigo Completes Acquisition of Leading Portfolio of OTC Brands from GSK 4Eubiotics Market Worth 7.05 Billion USD by 2020 2Eubiotics Market Worth 7.05 Billion USD by 2020 3Eubiotics Market Worth 7.05 Billion USD by 2020 4Eubiotics Market Worth 7.05 Billion USD by 2020 5
... VIEW, Calif., Jan. 21, 2011 VIVUS, Inc. (Nasdaq: ... meeting with the Food and Drug Administration (FDA) for the ... the treatment of obesity.  The meeting occurred on January 19th ... senior members of the FDA and VIVUS, management and consultants. ...
... Initiatives, Inc. (Nasdaq: MTXX ) ("Matrixx" or ... markets Zicam® products, today provided a summary of the ... of Merger, dated as of December 14, 2010, by ... Holdings Acquisition Corp. (the "Merger Agreement").  Pursuant to the ...
Cached Medicine Technology:VIVUS Provides Regulatory Update on QNEXA NDA 2VIVUS Provides Regulatory Update on QNEXA NDA 3Matrixx Initiatives, Inc. Summarizes Ongoing 'Go-Shop' Process and Board Reaffirms Recommendation 2Matrixx Initiatives, Inc. Summarizes Ongoing 'Go-Shop' Process and Board Reaffirms Recommendation 3Matrixx Initiatives, Inc. Summarizes Ongoing 'Go-Shop' Process and Board Reaffirms Recommendation 4Matrixx Initiatives, Inc. Summarizes Ongoing 'Go-Shop' Process and Board Reaffirms Recommendation 5
(Date:8/29/2015)... ... August 30, 2015 , ... Rio Salado College President Chris ... college’s Vice President of Strategic Initiatives and Information Services. O’Shea, who has served Rio ... expand its reach and impact through innovative technologies and strategies. , “I am very ...
(Date:8/29/2015)... ... August 29, 2015 , ... On Saturday, September 19, 2015, Diane Blackburn-Zambetti, ... (Meso Foundation) will present an educational program titled “Asbestos and Your Health.” , ... 9:30 PM (doors open at 6:45pm) at Calvary United Methodist Church, 16 E Park ...
(Date:8/29/2015)... ... August 29, 2015 , ... Targeted therapies, made ... the lives of patients, according to a newly published report. Surviving Mesothelioma has ... full article. , The authors of the new paper focus on several ...
(Date:8/29/2015)... NY (PRWEB) , ... August 29, 2015 , ... Next ... end of summer (which astronomically, officially ends on September 22nd this year). For IT ... cyber security hangovers linger on which could prove far more costly than a simple ...
(Date:8/29/2015)... ... August 29, 2015 , ... Hamstring strain ... stretching, soft tissue manipulation. Platelet rich plasma injections also have mixed results. ... improve treatment outcomes. This localized treatment seems to address the symptoms and ...
Breaking Medicine News(10 mins):Health News:Rio Salado College Appoints New Vice President of Strategic Initiatives and Information Services 2Health News:Mesothelioma Applied Research Foundation to Hold Educational Class About Asbestos and Mesothelioma Prevention 2Health News:Top Mesothelioma Researchers Highlight Targeted Therapies in New Report, According to Surviving Mesothelioma 2Health News:Business Cyber Security – Come Out of the Summer with a Clean Slate 2Health News:Business Cyber Security – Come Out of the Summer with a Clean Slate 3Health News:Business Cyber Security – Come Out of the Summer with a Clean Slate 4Health News:NEW APPROACH for Treatment of Recurrent Hamstring Strains and Hamstring Tendinosis is Available for the First Time in NYC 2Health News:NEW APPROACH for Treatment of Recurrent Hamstring Strains and Hamstring Tendinosis is Available for the First Time in NYC 3
... until it encounters a cancer cell, then suddenly activates and ... marks the latest step in scientists, efforts to tap the ... of the technology at the University of Rochester Medical Center ... machines produced in abundance by tumors to chew through and ...
... a major public health problem through its association with ... life expectancy rises around the world, along with the ... incidence of hip fractures is estimated to reach 6.3 ... of fracture in men and women. A new review ...
... on the words ,light, and ,mild, smokers in Western ... may be less harmful than others. In fact, ... of risk to smokers, including ,mild, and ,low-tar, brands. ... Addiction polled over 8000 smokers from Australia, Canada, ...
... Amanda Gardner HealthDay Reporter , MONDAY, April 11 ... primary care doctors often choose a different option than they ... In fact, physicians who were surveyed in the research more ... to have long-term repercussions, such as paralysis, than to die. ...
... University researcher has co-authored an international study that revealed a ... treat a rare lung disease in women. The life-threatening ... The clinical trial of the drug -- called sirolimus ... a therapy for the lung disease, lymphangioleiomyomatosis, or LAM. ...
... -- Long-term use of antibiotics to treat acne doesn,t ... medications, a new study finds. The finding came ... of antibiotics has been credited with encouraging antibiotic resistance ... Pennsylvania School of Medicine assessed the prevalence of ...
Cached Medicine News:Health News:A 'Pacman strategy' to boost the immune system to fight cancer 2Health News:A 'Pacman strategy' to boost the immune system to fight cancer 3Health News:Changing trends in hip fracture incidence around the world 2Health News:Smokers believe 'silver', 'gold' and 'slim' cigarettes are less harmful 2Health News:Doctors Often Wouldn't Follow Their Own Advice: Study 2Health News:Doctors Often Wouldn't Follow Their Own Advice: Study 3Health News:OHSU expert co-authors study finding treatment for rare lung disease 2Health News:Acne Antibiotics Not Linked to Drug Resistance 2
... most comprehensive family of lightweight standard ... incision, Glaucoma filtration, and Vitreoretinal uses. ... with minimal tissue trauma and minimal ... are available in 18, 20, and ...
... offers the most comprehensive family of ... for Cataract incision, Glaucoma filtration, and ... is achieved with minimal tissue trauma ... eraser styles are available in 18, ...
... most comprehensive family of lightweight standard ... incision, Glaucoma filtration, and Vitreoretinal uses. ... with minimal tissue trauma and minimal ... are available in 18, 20, and ...
... Medtronic Ophthalmics offers the most ... specialty Eraser Instruments for Cataract incision, ... and discrete coagulation is achieved with ... cellular necrosis. Straight eraser styles are ...
Medicine Products: